Fig. 1From: A comparative cost-effectiveness analysis of mechanical and pharmacological VTE prophylaxis after lower limb arthroplasty in AustraliaCost-effectiveness plane for pharmacoprophylaxis versus IPC. Each graph shows the cost-effectiveness plane for one method of VTE prophylaxis when compared to IPC. The change in QALYs (x-axis, pharmacoprophylaxis—IPC) is plotted against change in costs (y-axis, pharmacoprophylaxis—IPC). For comparative purposes, all graphs have the same axis ranges. Points falling below the diagonal line would be considered cost-effective at a willingness-to-pay (maximum cost that is considered acceptable for payers) threshold of AUD 50,000 per QALY gainedBack to article page